Influence of chronic liver disease on coronary atherosclerosis vulnerability features

International Journal of Cardiology

Volumn 109, Issue 3, 2006, Pages 387-391

  Otsubo, Roberto ^a   Higuchi, Maria de Lourdes ^a   Gutierrez, Paulo Sampaio ^a   Benvenuti, Luiz Alberto ^a   Massarollo, Paulo Celso Bosco ^a   Costa, Anderson Lino ^a   Ramires, José Antonio Franchini ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; Cirrhosis; Coronary artery disease

Indexed keywords

FAT;

ACCIDENT; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL OCCLUSION; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; DEATH; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; INFLAMMATION; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; POPULATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; AGED; CHRONIC DISEASE; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; FEMALE; HUMANS; LIPOPROTEINS, LDL; LIVER DISEASES; MALE; MIDDLE AGED;

EID: 33646244726     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.06.028     Document Type: Article

References (39)

1. Vanecek R. Atherosclerosis and cirrhosis of the liver. Bull World Health Organ Suppl 53 5-6 (1976) 567-570
2. Howell W.L., and Manion W.C. The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: a review of 639 cases of cirrhosis of the liver from 17731 autopsies. Am Heart J 60 3 (1960) 341-344
3. Hirst A.E., Hadley G.G., and Gore I. The effect of chronic alcoholism and cirrhosis of the liver on atherosclerosis. Am J Med Sci 249 (1965) 143-149
4. Parrish H.M., and Eberly A.L. Negative association of coronary atherosclerosis with liver cirrhosis and chronic alcoholism - a statistical fallacy. J Indiana Med Assoc 54 (1961) 341
5. Restrepo C., Montenegro M.R., and Solberg L.A. Atherosclerosis in persons with selected diseases. Lab Invest 18 5 (1968) 552-559
6. Bezerra H.G., Higuchi M.L., Gutierrez P.S., Palomino A.S., Silvestre J.M., Libby P., et al. Atheromas that cause fatal thrombosis are usually larger and frequently accompanied by vessel enlargement. Cardiovasc Pathol 10 4 (2001) 189-196
7. Pasterkamp G., Schoneveld A.H., van der Wal A.C., Haudenschild C.C., Clarijs R.J., Becker A.E., et al. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. J Am Coll Cardiol 32 3 (1998) 655-662
8. Qiao J.H., and Fishbein M.C. The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombosis. J Am Coll Cardiol 17 5 (1991) 1138-1142
9. Völzke H., Schwahn C., Wolff B., Mentel R., Robinson D.M., Kleine V., et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 174 1 (2004) 99-103
10. Smieja M., Gnarpe J., Lonn E., Gnarpe H., Olsson G., Yi Q., et al. Multiple infections and subsequent cardiovascular events in the heart outcomes prevention evaluation (HOPE) study. Circulation 107 2 (2003) 251-257
11. Higuchi M.L., Gutierrez P.S., Bezerra H.G., Palomino S.A., Allelo V.D., Silvestre J.M., et al. Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries. Arq Bras Cardiol 79 1 (2002) 20-24
12. Grant W.C., Wasserman F., Rodensky P.L., and Thompson R.V. The incidence of myocardial infarction in portal cirrhosis. Ann Intern Med 51 (1959) 774-779
13. Crippin J.S., Lindor K.D., Jorgensen R., Kottke B.A., Harrison J.M., Murtaugh P.A., et al. Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?. Hepatology 15 5 (1992) 858-862
14. Propst A., Propst T., Lechleitner M., Hoppichler F., Kathrein H., Vogel W., et al. Hypercholesterolemia in primary biliary cirrhosis is no risk factor for atherosclerosis. Dig Dis Sci 38 2 (1993) 379-380
15. Cecere A., Marotta F., Vangieri B., Tancredi L., and Gattoni A. Progressive liver injury in chronic hepatitis C infection is related to altered cellular immune response and to different citokine profile. Panminerva Med 46 3 (2004) 171-187
16. Barh M.J., and Manns M.P. Function of the immune system in liver cirrhosis. Z Gastroenterol 39 8 (2001) 601-607
17. Makishima T., Saito H., and Morioka Y. The effect of immunological response on wound healing in rat with liver cirrhosis. Nippon Geka Gakkai Zasshi 92 2 (1991) 144-149
18. Lee S.S. Cardiac abnormalities in liver cirrhosis. West J Med 151 5 (1989) 530-535
19. Ponz De Leon M., Loria P., Iori R., and Carulli N. Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size. Gastroenterology 80 6 (1981) 1428-1437
20. Tietge U.J., Boker K.H., Bahr M.J., Weinberg S., Pichimayr R., Schimdt H.H., et al. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Hepatogastroenterology 45 24 (1998) 2255-2260
21. Cicognani C., Malavolti M., Morselli-Labate A.M., Zamboni L., Sama C., and Barbara L. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med 157 7 (1997) 792-795
22. Jahn C.E., Schaefer E.J., Taam A.L., Hoofnagle J.H., Lindgren F.T., Albers J.J., et al. Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology 89 6 (1985) 1266-1278
23. Day R.C., Harry D.S., Owen J.S., Foo A.Y., and Mcintyre N. Lecithin-cholesterol acyltransferase and the lipoprotein abnormalities of parenchymal liver disease. Clin Sci (Lond) 56 6 (1979) 575-583
24. Cooper A.D., and Ellsworth J.L. Lipoprotein metabolism. In: Zakim D., and Boyer T. (Eds). Hepatology: a textbook of liver disease. 3th ed. (1993), Saunders, Philadelphia 92-130
25. Taus M., Ferretti G., Dói N., Moreau J., Battino M., Solera M.L., et al. Susceptibility to in vitro lipid peroxidation from liver cirrhotic patients. Scand J Clin Lab Invest 54 2 (1994) 147-153
26. Desai K., Mistry P., Bagget C., Burroughs A.K., Bellamy M.F., and Owens J.S. Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis. Lancet 1 8640 (1989) 693-696
27. Sposito A.C., Vinagre C.G., Ramires J.A., Pandullo F.L., Mies S., and Raia S. Apolipoprotein and lipid abnormalities in chronic liver failure. Braz J Med Biol Res 30 (1997) 1287-1290
28. Owen J.S., Goodall H., Mistry P., Harry D.S., Day R.C., and Mcintyre N. Abnormal high density lipoproteins from patients with liver disease regulate cholesterol metabolism in cultured human skin fibroblasts. J Lipid Res 25 9 (1984) 919-931
29. Vallance P., and Moncada S. Hypothesis: induction of nitric oxide synthase in the vasculature underlies the hyperdynamics circulation of cirrhosis. Lancet 337 (1991) 776
30. Battista S., Bar F., Mengozzi G., Zanon F., Grosso M., and Molino G. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. J Hepatol 26 (1997) 75-80
31. Cooke J.P., and Tsao P.S. Is nitric oxide an endogenous antiatherogenic molecule?. Arterioscler Thromb 14 5 (1994) 653-655
32. Tsao P.S., Mcevoy L.M., Drexler H., Butcher E.C., and Cooke J.P. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by l-arginine. Circulation 89 5 (1994) 2176-2182
33. Among M., Menger M.D., and Vollmar B. Heme oxygenase and nitric oxide synthase mediate cooling-associated protection against TNF-alpha-induced microcirculatory dysfunction and apoptotic cell death. FASEB J 17 (2003) 175-185
34. Bannister P., and Losowsky M.S. Sex hormones and chronic liver disease. J Hepatol 6 2 (1988) 258-262
35. Mendelsohn M.E., and Kara R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340 23 (1999) 1801-1811
36. Castilla A., Prieto J., and Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 324 14 (1991) 933-940
37. Friedman S.L. Alcoholic liver disease, cirrhosis, and its major sequelae. In: Goldman L., and Bennett J.C. (Eds). Textbook of medicine. 21th ed. (2000), Saunders, Cecil 805-812
38. Lefer A.M., Tsao P.S., Lefer D.J., and Ma X.L. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 5 7 (1991) 2029-2034
39. Grainger D.J., and Metcalfe J.C. A pivotal role for TGF-beta in atherogenesis?. Biol Ver Camb Philos Soc 70 4 (1995) 571-596